Public Health | November 25, 2021
Gastrointestinal disorders increasing in India
It is estimated that one-third of our country’s population has some form of these disorders
It is estimated that one-third of our country’s population has some form of these disorders
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
The approval was granted by Agenzia Italiana del Farmaco
All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks
Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease
The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
The country’s strength lies not just in technology availability but in adoption behaviour
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Subscribe To Our Newsletter & Stay Updated
